This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Sagent Pharmaceuticals Inc (SGNT)

NASDAQ: Health Care

Company Balance Sheet
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Assets
Cash and Equivalents 55.63M 42.33M 27.69M 52.20M
Receivables 44.94M 26.68M 33.05M 31.41M
Inventories 61.78M 46.48M 47.11M 41.49M
Other Current Assets 0.00 0.00 0.00 0.00
Total Current Assets 198.52M 235.79M 147.27M 200.85M
Property, Plant & Equipment, Gross 78.42M 60.39M 1.87M 1.76M
Accumulated Depreciation & Depletion 7.27M 2.71M 1.09M 872.00K
Property, Plant & Equipment, Net 71.15M 57.68M 780.00K 884.00K
Intangibles 65.58M 8.33M 4.28M 5.43M
Other Non-Current Assets 4.91M 2.37M 19.99M 23.35M
Total Non-Current Assets 182.97M 74.42M 25.05M 29.66M
Liabilities & Shareholder Equity
Total Assets 381.49M 310.21M 172.32M 230.51M
Accounts Payable 40.79M 28.07M 28.84M 39.71M
Short Term Debt 508.00K 10.33M 0.00 8.18M
Other Current Liabilities 1.04M 4.28M 0.00 0.00
Total Current Liabilities 85.55M 63.52M 40.45M 84.14M
Long Term Debt 1.94M 0.00 0.00 4.09M
Deferred Income Taxes 15.71M 0.00 0.00 0.00
Other Non-Current Liabilities 2.53M 10.66M 6.00K 606.00K
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 20.18M 10.66M 6.00K 4.70M
Total Liabilities 105.74M 74.18M 40.46M 88.84M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 275.75M 236.03M 131.86M 141.67M
Common Par 320.00K 318.00K 281.00K 279.00K
Additional Paid In Capital 352.98M 349.28M 272.72M 266.06M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -74.18M -114.06M -143.65M -126.83M
Treasury Stock 0.00 0.00 0.00 0.00
Other Equity Adjustments -3.37M 487.00K 2.50M 2.16M
Total Capitalization 277.70M 236.03M 131.86M 145.76M
Total Equity 275.75M 236.03M 131.86M 141.67M
Total Liabilities & Stock Equity 381.49M 310.21M 172.32M 230.51M
Total Common Shares Outstanding 31.98M 31.79M 28.12M 27.90M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 0.00 0.00 0.00 0.00
Basic Weighted Shares Outstanding 31.88M 29.21M 27.98M 20.10M
Diluted Weighted Shares Outstanding 32.74M 29.94M 27.98M 20.10M
Number of Employees 466 269 98 99
Number of Part-Time Employees 0 0 0 0
SGNT News

SGNT Sagent Pharmaceuticals Inc

Analysts Ratings for SGNT

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 1 1 1 1
Moderate Buy 0 0 0 0
Hold 6 6 6 6
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET SGNT ANALYST REPORT

Brokerage Partners

SGNT Chatter

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Growth Seeker

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs